For Sirna, Talks on Drug-Development Deal Turn Into $1.1B Bet by Merck - RNAi

For Sirna, Talks on Drug-Development Deal Turn Into $1.1B Bet by Merck
By Doug Macron
November 2, 2006
RNAi News
?We had no intention of selling the company,? according to a Sirna official. But in the end the price offered by Merck, which has been one of the first drug giants to place big bets in RNAi, proved too good to pass up.
Paid subscription is required to view article.